Our lab is studying the mechanisms that underlie mammalian pancreas organogenesis and pancreatic diseases, including diabetes and pancreatic cancer ๐งซ๐ฌ
Munich
Joined January 2023
- Tweets18
- Following38
- Followers188
- Likes12
Hebrok Lab retweeted
Thrilled to share one of our biggest discoveries: โInceptor binds to and directs insulin towards lysosomal degradation in beta cellsโ.
doi.org/10.1038/s42255-024-0โฆ
A tremendous collaborative effort led by @JohannaSiehler, @BilekovaSara and other members of the @LickertHeiko lab.
Hebrok Lab retweeted
For the first time in more than a decade, the FDA has approved a new first-line treatment for patients with metastatic #pancreaticcancer, called NALIRIFOX.
After a clinical trial showed a positive survival benefit, the combination chemotherapy called NALIRIFOX is now approved for patients who have not received any previous treatment. For a disease with limited treatment options, this is exciting news. ๐
We've answered some of the most common questions related to this new treatment option at pcan.at/s2nut9.
If you have additional questions, you can contact PanCAN Patient Services at ๐ฑ 877-2- PANCAN or ๐ง [email protected]. Our Case Managers can help you understand your options and connect you with resources to learn more.
ALT FDA Approves New First-line Treatment Option for Metastatic Pancreatic Cancer
Hebrok Lab retweeted
Pancreatic organoids๐จโ๐ฌ
๐This is what Matthias Hebrok, director of our new Institute for #Diabetes & #Organoid Technology focuses on.
๐กHis goal: Finding new paths for novel therapies for #diabetes & #pancreaticCancer.
๐Read about his spirit & ideas:
๐t1p.de/0dkxh
ALT Matthias Hebrok, director of our new Institute for Diabetes & Organoid Technology, focuses on pancreatic organoids.
Hebrok Lab retweeted
Diabetes Germany reunion at FC Bayern game in Munich. โฆ@LickertHeikoโฉ, Matthias Hebrok. โฆ@MatthiasTschopโฉ and Stephan Herzig with season tickets.
Hebrok Lab retweeted
๐ขWe have a new member in the club: The ๐๐ป๐๐๐ถ๐๐๐๐ฒ ๐ณ๐ผ๐ฟ ๐๐ถ๐ฎ๐ฏ๐ฒ๐๐ฒ๐ ๐ฎ๐ป๐ฑ ๐ข๐ฟ๐ด๐ฎ๐ป๐ผ๐ถ๐ฑ ๐ง๐ฒ๐ฐ๐ต๐ป๐ผ๐น๐ผ๐ด๐ (๐๐๐ข๐ง), led by Matthias Hebrok, was founded in September 2022!
We are very much looking forward to working together! ๐
#WelcomeToTheFamily
